Found 8 hits for monomerid = 50338267 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Elan Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay |
Bioorg Med Chem Lett 21: 1838-43 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.046 BindingDB Entry DOI: 10.7270/Q2Q52PX0 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 9
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Elan Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay |
Bioorg Med Chem Lett 21: 1838-43 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.046 BindingDB Entry DOI: 10.7270/Q2Q52PX0 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Elan Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay |
Bioorg Med Chem Lett 21: 1838-43 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.046 BindingDB Entry DOI: 10.7270/Q2Q52PX0 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 9
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| US Patent
| n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
IMAGO PHARMACEUTICALS, INC.
US Patent
| Assay Description (1) Assay buffer #1 with 0.0025% Tween and 1 mM DTT was prepared using JNK buffer stock solution.(2) Assay buffer #2 with 0.025% BSA was prepared usi... |
US Patent US9796706 (2017)
BindingDB Entry DOI: 10.7270/Q24T6MHK |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 1
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 3.51E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Elan Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant ERK2 after 60 mins by TR-FRET assay |
Bioorg Med Chem Lett 21: 1838-43 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.046 BindingDB Entry DOI: 10.7270/Q2Q52PX0 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| US Patent
| n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
IMAGO PHARMACEUTICALS, INC.
US Patent
| Assay Description (1) Assay buffer #1 with 0.0025% Tween and 1 mM DTT was prepared using JNK buffer stock solution.(2) Assay buffer #2 with 0.025% BSA was prepared usi... |
US Patent US9796706 (2017)
BindingDB Entry DOI: 10.7270/Q24T6MHK |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| US Patent
| n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
IMAGO PHARMACEUTICALS, INC.
US Patent
| Assay Description (1) Assay buffer #1 with 0.0025% Tween and 1 mM DTT was prepared using JNK buffer stock solution.(2) Assay buffer #2 with 0.025% BSA was prepared usi... |
US Patent US9796706 (2017)
BindingDB Entry DOI: 10.7270/Q24T6MHK |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50338267
(CHEMBL1682021 | N-(4-cyano-3-(1H-1,2,4-triazol-5-y...)Show SMILES O=C(Cc1cccc2ncccc12)Nc1scc(C#N)c1-c1nnc[nH]1 Show InChI InChI=1S/C18H12N6OS/c19-8-12-9-26-18(16(12)17-21-10-22-24-17)23-15(25)7-11-3-1-5-14-13(11)4-2-6-20-14/h1-6,9-10H,7H2,(H,23,25)(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Elan Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay |
Bioorg Med Chem Lett 21: 1838-43 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.046 BindingDB Entry DOI: 10.7270/Q2Q52PX0 |
More data for this Ligand-Target Pair | |